Aarhus University Seal / Aarhus Universitets segl

Testing patients during seizures: A European consensus procedure developed by a joint taskforce of the ILAE - Commission on European Affairs and the European Epilepsy Monitoring Unit Association

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

DOI

  • Sándor Beniczky
  • Miri Neufeld, The EEG and Epilepsy Unit, Department of Neurology, Tel Aviv Medical Center, Tel Aviv, Israel.
  • ,
  • Beate Diehl, Departments of Clinical Neurophysiology and Clinical and Experimental Epilepsy, Institute of Neurology, National Hospital for Neurology and Neurosurgery, University College London, London, United Kingdom.
  • ,
  • Judith Dobesberger, Department of Neurology, Christian-Doppler-Klinik, Paracelsus Medical University, and Center for Cognitive Neuroscience, Salzburg, Austria.
  • ,
  • Eugen Trinka, Department of Neurology, Christian-Doppler-Klinik, Paracelsus Medical University, and Center for Cognitive Neuroscience, Salzburg, Austria.
  • ,
  • Ruta Mameniskiene, Clinic of Neurology and Neurosurgery, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
  • ,
  • Sylvain Rheims, Department of Functional Neurology and Epileptology, University Hospital of Lyon and Lyon 1 University, Lyon, France.
  • ,
  • Antonio Gil-Nagel, Department of Neurology, Epilepsy Program, Hospital Ruber Internacional, Madrid, Spain.
  • ,
  • Dana Craiu, Department of Clinical Neurosciences (No. 6), Pediatric Neurology Clinic, Alexandru Obregia Hospital, "Carol Davila" University of Medicine, Bucharest, Romania.
  • ,
  • Ronit Pressler, Department of Clinical Neurophysiology, Great Ormond Street Hospital, London, United Kingdom.
  • ,
  • David Krysl, Departments of Clinical Neurophysiology and Neurology, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • ,
  • Angelina Lebedinsky, *Department of Clinical Neurophysiology, Danish Epilepsy Centre, Dianalund, Denmark; †Department of Neuroimaging, Institute of Psychiatry, King's College London, London, United Kingdom; ‡Department of Neurology, Bethesda Children's Hospital, Budapest, Hungary; §Department of Clinical Neurophysiology, Aarhus University Hospital, Aarhus, Denmark; ‖Department of Clinical Neurophysiology, University of Copenhagen Glostrup Hospital, Glostrup, Denmark; ¶Research Department, BESA GmbH, Gräfelfing, Germany; #The EEG and Epilepsy Unit, Department of Neurology, Tel Aviv Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; **Great Ormond Street Hospital for Children NHS Trust, Department of Clinical Neurophysiology, London, United Kingdom; ††Department of Clinical Neurophysiology, Rigshospitalet University Hospital, Copenhagen, Denmark; and ‡‡Dutch Epilepsy Clinics Foundation (S.E.I.N.), Department of Clinical Neurophysiology, Heemstede, The Netherlands.
  • ,
  • Laura Tassi, "Claudio Munari" Epilepsy Surgery Center, Niguarda Hospital, Milan, Italy.
  • ,
  • Guido Rubboli, Danish Epilepsy Center and University of Copenhagen, Dianalund, Denmark.
  • ,
  • Philippe Ryvlin, Department of Clinical Neurosciences, CHUV, Lausanne, Switzerland.

There is currently no international consensus procedure for performing comprehensive periictal testing of patients in the epilepsy monitoring units (EMUs). Our primary goal was to develop a standardized procedure for managing and testing patients during and after seizures in EMUs. The secondary goal was to assess whether it could be implemented in clinical practice (feasibility). A taskforce was appointed by the International League Against Epilepsy (ILAE)-Commission on European Affairs and the European Epilepsy Monitoring Unit Association, to develop a standardized ictal testing battery (ITB) based on expert opinion and experience with various local testing protocols. ITB contains a comprehensive set of 10 items that evidence the clinically relevant semiologic features, and it is adaptive to the dynamics of the individual seizures. The feasibility of the ITB was prospectively evaluated on 250 seizures from 152 consecutive patients in 10 centers. ITB was successfully implemented in clinical practice in all 10 participating centers and was considered feasible in 93% of the tested seizures. ITB was not feasible for testing seizures of very short duration.

Original languageEnglish
JournalEpilepsia
Volume57
Issue9
Pages (from-to)1363-8
Number of pages6
ISSN0013-9580
DOIs
Publication statusPublished - Sep 2016

    Research areas

  • Journal Article

See relations at Aarhus University Citationformats

ID: 109014953